CTLA4 and cancer: Collectively, the PD-1/PD-L1 and CTLA-4 (Figure 5H), which are commonly employed in cancer immunotherapy, exhibited notable distinctions between the three clusters, suggesting that the expression patterns of lncRNAs were associated with the immune checkpoints in cancer.